For patients with CKD and atrial fibrillation, anticoagulants are linked with an increased risk of ischemic stroke.
Blacks are at an increased risk of developing ischemic stroke, before or after atrial fibrillation diagnosis.
CHA2DS2-VASc score assessment is more predictive of ischemic stroke in patients with atrial fibrillation than the baseline score.
Although there was little difference in efficacy, apixaban did have a better safety profile than warfarin, dabigatran, and rivaroxaban.
Updated antithrombotic therapy recommendations for patients with atrial fibrillation have been provided.
Ablation is associated with reduced risk of recurrent stroke for patients with artrial fibrillation.
Risk scores help identify high-risk patients who may benefit from intervention.
Mechanisms including silent cerebral infarct, microemboli, microbleedings, and cerebral hypoperfusion may be responsible for the link between atrial fibrillation and cognitive decline.
The investigators noted that rivaroxaban was associated with significantly reduced length of hospital stay compared with warfarin.
Dual therapy was associated with a significantly higher bleeding risk.
Delays in anticoagulation treatment resulted in increased risk for dementia.
Neglecting abnormalities in ECG readings could result in serious acute cardiac events in patients presenting with stroke.
Patients taking apixaban showed significantly less intracranial hemorrhage (0.33% per year) vs patients taking warfarin (0.80% per year), no matter the type and location.
More than 80% of ischemic stroke patients weren't getting adequate anticoagulation therapy.
Clinicians should closely monitor patients with atrial fibrillation, especially if they are female and of increasing age.
Early intervention in patients with heart failure or atrial fibrillation may help delay or prevent the onset of mild dementia.
It is not clear if identifying atrial fibrillation in an effort to prevent stroke would be an effective preventive strategy.
The increased risk of stroke was only observed among patients with diabetes controlled by insulin.
At 1 year, no difference in complications was observed between the 2 age groups.
Twelve months after AFib ablation, risk of recurrent stroke or AFib is low.
Only 46% of patients with indications received OACs at discharge from the hospital.
32.1% believed that heart attack is a major risk factor of AF, which is incorrect.
Reduced REM sleep was correlated with a 23% increased risk of atrial fibrillation, while insomnia was associated with a 29% increased risk.
Long episodes of AT/AF were more likely to be associated with clinical events than short episodes.
Patients with untreated OSA face an increased risk of complications.
Treating older patients with a vitamin K antagonist may be warranted since thrombosis risk is more markedly increased than bleeding risk with rising age.
Patients who were on the anticoagulant had an increase risk of dementia independent of atrial fibrillation.
The incidence of atrial fibrillation in stroke patients with an insertable cardiac monitor was higher than that reported previously.
The authors suggest that physicians may be concerned about bleeding risk.
A-fib was associated with central apnea, Cheyne Stokes respiration, apnea hypopnea index in older men.
Neurology Advisor Articles
- Visual Association Test, MMSE Highly Predictive of Dementia in Older Adults
- Epilepsy's Mobility Problem: Advocating for Changes in Transportation Laws, Public Resources
- The Future of Freezing of Gait in Parkinson's: Exploring Potential Treatments and Preventive Strategies
- Women With Epilepsy More Likely to Have Major Depressive Disorder
- Some Common Allergies Linked to Odds of Autism in Children
- CAPPRI Scale is Feasible for Assessing Health-Related Quality of Life in Diabetic Distal Sensorimotor Polyneuropathy
- Long-Term Type 1 Diabetes Associated With Cognitive Decline
- White Matter Hyperintensities in RCVS Vary Over Time
- Disrupted Thalamo-Striato-Hypothalamic Function May Serve as a Good Biomarker for Parkinson Disease
- Levetiracetam Effective as Episodic Migraine Prophylactic